Finance

Lists
002873:SHE
Guiyang Xintian Pharmaceutical Co Ltd
CN¥8,43
-1,40%
(-0,12) 1D
12 Okt., 15:04:18 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002873...
Open
CN¥8,60
High
CN¥8,71
Low
CN¥8,35
Mkt. cap
2,09 mjd
Avg. vol.
5,54 m
Volume
4,90 m
Dividend
0,36%
Quarterly dividend
CN¥0,01
Ex-dividend date
27 Mei 2026
P/E ratio
287,81
52-wk high
CN¥13,09
52-wk low
CN¥7,04
EPS
CN¥0,03
Shares outstanding
244,10 m
No. of employees
1 k
Open
CN¥8,60
High
CN¥8,71
Low
CN¥8,35
Mkt. cap
2,09 mjd
Avg. vol.
5,54 m
Volume
4,90 m
Dividend
0,36%
Quarterly dividend
CN¥0,01
Ex-dividend date
27 Mei 2026
P/E ratio
287,81
52-wk high
CN¥13,09
52-wk low
CN¥7,04
EPS
CN¥0,03
Shares outstanding
244,10 m
No. of employees
1 k
News stories
From web sources and news partners
About Guiyang Xintian Pharmaceutical Co Ltd
CEO-
Employees1,39 k
Founded11 Aug. 1995
Headquarters-
SectorPharmaceutical industry
Websitegyxtyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
200,35 m
191,09 m
178,61 m
153,22 m
Cost of goods sold
54,09 m
59,09 m
49,13 m
42,43 m
Cost of revenue
54,09 m
59,09 m
49,13 m
42,43 m
Research and development expenses
12,03 m
10,41 m
9,30 m
11,42 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114,04 m
125,40 m
106,18 m
92,88 m
Operating expense
130,34 m
137,34 m
118,71 m
105,01 m
Total operating expenses
184,43 m
196,43 m
167,84 m
147,44 m
Operating income
15,92 m
-5,35 m
10,77 m
5,77 m
Other non operating income
-215,68 k
505,88 k
-40,98 k
-495,16 k
EBT including unusual items
10,40 m
-6,90 m
5,25 m
2,96 m
EBT excluding unusual items
11,83 m
-9,94 m
6,33 m
1,11 m
Income tax expense
-13,00 k
167,36 k
1,75 m
1,60 m
Effective tax rate
-0,12%
-2,42%
33,37%
53,89%
Other operating expenses
5,16 m
1,56 m
3,83 m
2,23 m
Net income
10,41 m
-7,07 m
3,50 m
1,37 m
Net profit margin
5,20%
-3,70%
1,96%
0,89%
Earnings per share
-
-
-
-
Interest and investment income
84,26 k
124,27 k
95,66 k
192,47 k
Interest expense
-3,96 m
-5,23 m
-4,50 m
-4,36 m
Net interest expenses
-3,88 m
-5,10 m
-4,40 m
-4,17 m
Depreciation and amortization charges
-
-
-
-
EBITDA
23,68 m
2,87 m
18,99 m
14,09 m
Gain or loss from assets sale
-845,41 k
781,86 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme